Cargando…
Association between dyslipidemia and antihypertensive and antidiabetic treatments in a China multicenter study
Dyslipidemia is an emerging disease in China, especially in the presence of hypertension and diabetes mellitus. We investigated the association of dyslipidemia with the use of antihypertensive and antidiabetic agents. The study participants (n = 2423) were hypertensive and diabetic patients enrolled...
Autores principales: | Miao, Chao‐Ying, Ye, Xiao‐Fei, Zhang, Wei, Ji, Li‐Nong, Wang, Ji‐Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678804/ https://www.ncbi.nlm.nih.gov/pubmed/34092020 http://dx.doi.org/10.1111/jch.14264 |
Ejemplares similares
-
The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐sectional population study
por: Zhang, Fomin, et al.
Publicado: (2021) -
Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry
por: Ye, Xiao‐Fei, et al.
Publicado: (2023) -
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
por: Tang, Bowen, et al.
Publicado: (2023) -
Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study
por: Rida, Elyamani, et al.
Publicado: (2020) -
Personalized antihypertensive treatment guided by pharmacogenomics in China
por: Xiao, Zhi-Lin, et al.
Publicado: (2022)